CNS PHARMACEUTICALS INC - COM NEW (CNSP)

CUSIP: 18978H201

Q2 2023 13F Holders as of 30 Jun 2023

Share change
-85,248
SEC-reported price per share
$2.23
Number of holders
12
Value change
+$26,223
Number of buys
7
Number of sells
9

Security key

18978H201

Report period

Q2 2023

Institutions

12

Top holders

10

Ownership snapshot

Top reported holders of CNSP - CNS PHARMACEUTICALS INC - COM NEW (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Waldemar Priebe
Disclosed value leader
Waldemar Priebe
Comparable rows
0/14
Latest evidence
31 Mar 2023
3/4/5 13F Highest disclosed value: $198,486 14 rows are not safely comparable across share classes. Showing 1-6 of 14 holder rows.

Quick read

Waldemar Priebe has the largest disclosed position value at $198.5K.

0 of 14 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Waldemar Priebe's linked filing trail.
Disclosed position value Top 5
Waldemar Priebe $198.5K
ARMISTICE CAPITAL, LLC $124K
RENAISSANCE TECHNOLOGIES LLC $27K
CITADEL ADVISORS LLC $13.2K
Tower Research Capital LLC (TRC) $12K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 14 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Waldemar Priebe
3/4/5
10%+ Owner
—
denominator unverified
$198,486
156,807 shares
— 06 Dec 2022
ARMISTICE CAPITAL, LLC
13F
Company
13F
—
denominator unverified
$124,000
124,000 shares
— 31 Mar 2023
RENAISSANCE TECHNOLOGIES LLC
13F
Company
13F
—
denominator unverified
$27,000
26,800 shares
— 31 Mar 2023
CITADEL ADVISORS LLC
13F
Company
13F
—
denominator unverified
$13,196
13,196 shares
— 31 Mar 2023
Tower Research Capital LLC (TRC)
13F
Company
13F
—
denominator unverified
$12,000
11,702 shares
— 31 Mar 2023
Virtu Financial LLC
13F
Company
13F
—
denominator unverified
$11,000
11,119 shares
— 31 Mar 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
12
Shares
104,795
Rows available
12
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders
13
Q2 2023 holders
12
Holder diff
-1
Investor Q1 2023 Shares Q2 2023 Shares Share Diff Share Chg % Q1 2023 value Q2 2023 value Value change Value Chg %
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .